Skip to main content

Registration
IDWeek Learning Objective
Return to Sessions
and Exhibits
Chasing the Sun
Schedule
Speakers
Oral Abstracts
Posters
Featured Speakers
FAQ

IDWeek 2020 Main banner

Registration
IDWeek Learning Objective
Return to Sessions
and Exhibits
Chasing the Sun
Schedule
Speakers
Oral Abstracts
Posters
Featured Speakers
FAQ

Tweets by IDWeek 2020

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Chasing the Sun

Live

On Demand

Favorite
0 Like
Facebook
Tweet this
Print

Surya Chitra, PhD

Biostatistics Consultant
Paratek Pharmaceuticals, Inc.

Disclosure: Paratek Pharmaceuticals, Inc. (Consultant)

Poster(s):

1492 - Targeted Substitution of Omadacycline in Place of Standard of Care for CABP Treatment is Associated with a Risk Reduction of Clostridioides difficile Infection and Financial Cost Savings in the Acute Care Setting
1687 - Omadacycline in Female Adults With Acute Pyelonephritis: Results from a Randomized, Double-Blind, Adaptive Phase 2 Study
1688 - Omadacycline in Female Adults With Cystitis: Results From a Randomized, Double-Blinded, Adaptive Phase 2 Study

Designed by CadmiumCD |Technical Support |Give Feedback
© Copyright 2024 CadmiumCD. All Rights Reserved.